These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11236855)

  • 1. Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings.
    Giesler RB; Miles BJ; Cowen ME; Kattan MW
    Qual Life Res; 2000; 9(6):645-65. PubMed ID: 11236855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.
    Litwin MS; Hays RD; Fink A; Ganz PA; Leake B; Brook RH
    Med Care; 1998 Jul; 36(7):1002-12. PubMed ID: 9674618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimensions of quality of life expressed by men treated for metastatic prostate cancer.
    Clark JA; Wray N; Brody B; Ashton C; Giesler B; Watkins H
    Soc Sci Med; 1997 Oct; 45(8):1299-309. PubMed ID: 9381242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
    Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
    Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of patient preferences among men with prostate cancer.
    Albertsen PC; Nease RF; Potosky AL
    J Urol; 1998 Jan; 159(1):158-63. PubMed ID: 9400461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.
    Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M
    Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-cultural validation of the UCLA prostate cancer index.
    Karakiewicz PI; Kattan MW; Tanguay S; Elhilali MM; Bazinet M; Scardino PT; Aprikian AG
    Urology; 2003 Feb; 61(2):302-7. PubMed ID: 12597935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assessed health-related quality of life in men who have completed radiotherapy for prostate cancer: instrument validation and its relation to patient-assessed bother of symptoms.
    Wang H; Huang E; Dale W; Campbell T; Ignacio L; Kopnick M; Ray P; Vijayakumar S
    Int J Cancer; 2000 Jun; 90(3):163-72. PubMed ID: 10900429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assessed health-related quality of life in men being treated for prostate cancer with radiotherapy: instrument validation and its relation to patient-assessed bother of symptoms.
    Dale W; Campbell T; Ignacio L; Song P; Kopnick M; Mamo C; Ray P; Vijayakumar S
    Urology; 1999 Feb; 53(2):359-66. PubMed ID: 9933055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30.
    Borghede G; Sullivan M
    Qual Life Res; 1996 Apr; 5(2):212-22. PubMed ID: 8998490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer.
    Gilbert SM; Dunn RL; Hollenbeck BK; Montie JE; Lee CT; Wood DP; Wei JT
    J Urol; 2010 May; 183(5):1764-9. PubMed ID: 20299056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric Validation of the Sexual Distress Scale in Men with Prostate Cancer.
    Santos-Iglesias P; Walker LM
    J Sex Med; 2018 Jul; 15(7):1010-1020. PubMed ID: 29960626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an instrument to assess the needs of men diagnosed with prostate carcinoma: an assessment of the validity and reliability of a self-administered questionnaire developed to measure the needs experienced by men diagnosed with prostate carcinoma.
    Duke JM; Treloar CJ; Byles JE
    Cancer; 2003 Feb; 97(4):993-1001. PubMed ID: 12569598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development.
    Befort CA; Zelefsky MJ; Scardino PT; Borrayo E; Giesler RB; Kattan MW
    Clin Prostate Cancer; 2005 Sep; 4(2):100-8. PubMed ID: 16197610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale.
    Hollen PJ; Gralla RJ; Kris MG; Cox C; Belani CP; Grunberg SM; Crawford J; Neidhart JA
    Cancer; 1994 Apr; 73(8):2087-98. PubMed ID: 8156514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of ESCAP-CD as an instrument of measure for the evaluation of the quality of life in prostatic cancer. Part 2a].
    Morales López A; Grau Fibla G; Campoy Martínez P; Benavente Rodríguez A; Pascual del Pobil Moreno JL
    Actas Urol Esp; 2002 May; 26(5):320-34. PubMed ID: 12174740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Patient-Reported Outcomes Thermometer-5-Item Scale (5T-PROs): Validation of a New Tool for the Quick Assessment of Overall Health Status in Painful Rheumatic Diseases.
    Salaffi F; Di Carlo M; Carotti M; Farah S
    Pain Res Manag; 2018; 2018():3496846. PubMed ID: 30425755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
    Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
    Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Research and Treatment of Cancer. Core Quality of Life Questionnaire.
    Stockler MR; Osoba D; Corey P; Goodwin PJ; Tannock IF
    J Clin Epidemiol; 1999 Jul; 52(7):653-66. PubMed ID: 10391659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.